DE
PHVS icon

DV Equities’s Pharvaris PHVS Stock Holding History

DV Equities’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7M Buy
+482,524
New +$14.6M 2.39% 9

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DV Equities's PHVS Position: Q2 2026 in Review

DV Equities opened a new position in Pharvaris (PHVS) in Q2 2026: 482,524 shares worth $16.7M. The stake represents 2.39% of the portfolio and ranks #9 among its holdings.

125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • DV Equities held 482,524 shares of Pharvaris worth $16.7M as of Q2 2026.
  • Pharvaris was a new DV Equities position in Q2 2026.
  • Pharvaris made up 2.39% of DV Equities's portfolio in Q2 2026, its #9 holding.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on DV Equities's 13F filing for Q2 2026, filed 14 Aug 2026.